237 related articles for article (PubMed ID: 21732180)
1. The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection.
Reed JS; Sidney J; Piaskowski SM; Glidden CE; León EJ; Burwitz BJ; Kolar HL; Eernisse CM; Furlott JR; Maness NJ; Walsh AD; Rudersdorf RA; Bardet W; McMurtrey CP; O'Connor DH; Hildebrand WH; Sette A; Watkins DI; Wilson NA
Immunogenetics; 2011 Dec; 63(12):789-807. PubMed ID: 21732180
[TBL] [Abstract][Full Text] [Related]
2. The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239.
Loffredo JT; Sidney J; Piaskowski S; Szymanski A; Furlott J; Rudersdorf R; Reed J; Peters B; Hickman-Miller HD; Bardet W; Rehrauer WM; O'Connor DH; Wilson NA; Hildebrand WH; Sette A; Watkins DI
J Immunol; 2005 Nov; 175(9):5986-97. PubMed ID: 16237093
[TBL] [Abstract][Full Text] [Related]
3. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
Loffredo JT; Sidney J; Wojewoda C; Dodds E; Reynolds MR; Napoé G; Mothé BR; O'Connor DH; Wilson NA; Watkins DI; Sette A
J Immunol; 2004 Oct; 173(8):5064-76. PubMed ID: 15470050
[TBL] [Abstract][Full Text] [Related]
4. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins.
Mothé BR; Sidney J; Dzuris JL; Liebl ME; Fuenger S; Watkins DI; Sette A
J Immunol; 2002 Jul; 169(1):210-9. PubMed ID: 12077247
[TBL] [Abstract][Full Text] [Related]
6. CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.
Allen TM; Mothé BR; Sidney J; Jing P; Dzuris JL; Liebl ME; Vogel TU; O'Connor DH; Wang X; Wussow MC; Thomson JA; Altman JD; Watkins DI; Sette A
J Virol; 2001 Jan; 75(2):738-49. PubMed ID: 11134287
[TBL] [Abstract][Full Text] [Related]
7. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.
Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ
J Virol; 2014 Dec; 88(24):14310-25. PubMed ID: 25275134
[TBL] [Abstract][Full Text] [Related]
8. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
[TBL] [Abstract][Full Text] [Related]
9. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
Mothé BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI
J Virol; 2002 Jan; 76(2):875-84. PubMed ID: 11752176
[TBL] [Abstract][Full Text] [Related]
10. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
[TBL] [Abstract][Full Text] [Related]
11. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.
Loffredo JT; Sidney J; Bean AT; Beal DR; Bardet W; Wahl A; Hawkins OE; Piaskowski S; Wilson NA; Hildebrand WH; Watkins DI; Sette A
J Immunol; 2009 Jun; 182(12):7763-75. PubMed ID: 19494300
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.
Martins MA; Tully DC; Cruz MA; Power KA; Veloso de Santana MG; Bean DJ; Ogilvie CB; Gadgil R; Lima NS; Magnani DM; Ejima K; Allison DB; Piatak M; Altman JD; Parks CL; Rakasz EG; Capuano S; Galler R; Bonaldo MC; Lifson JD; Allen TM; Watkins DI
J Virol; 2015 Nov; 89(21):10802-20. PubMed ID: 26292326
[TBL] [Abstract][Full Text] [Related]
13. Acute-Phase CD4
Sutton MS; Ellis-Connell A; Moriarty RV; Balgeman AJ; Gellerup D; Barry G; Weiler AM; Friedrich TC; O'Connor SL
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111562
[TBL] [Abstract][Full Text] [Related]
14. Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides.
Schafer JL; Ries M; Guha N; Connole M; Colantonio AD; Wiertz EJ; Wilson NA; Kaur A; Evans DT
PLoS Pathog; 2015 Sep; 11(9):e1005145. PubMed ID: 26333068
[TBL] [Abstract][Full Text] [Related]
15. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
Allen TM; Sidney J; del Guercio MF; Glickman RL; Lensmeyer GL; Wiebe DA; DeMars R; Pauza CD; Johnson RP; Sette A; Watkins DI
J Immunol; 1998 Jun; 160(12):6062-71. PubMed ID: 9637523
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.
Loffredo JT; Friedrich TC; León EJ; Stephany JJ; Rodrigues DS; Spencer SP; Bean AT; Beal DR; Burwitz BJ; Rudersdorf RA; Wallace LT; Piaskowski SM; May GE; Sidney J; Gostick E; Wilson NA; Price DA; Kallas EG; Piontkivska H; Hughes AL; Sette A; Watkins DI
PLoS One; 2007 Nov; 2(11):e1152. PubMed ID: 18000532
[TBL] [Abstract][Full Text] [Related]
18. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL
Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438
[TBL] [Abstract][Full Text] [Related]
19. Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers.
Mudd PA; Ericsen AJ; Burwitz BJ; Wilson NA; O'Connor DH; Hughes AL; Watkins DI
J Immunol; 2012 Apr; 188(7):3364-70. PubMed ID: 22387557
[TBL] [Abstract][Full Text] [Related]
20. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.
Evans DT; Jing P; Allen TM; O'Connor DH; Horton H; Venham JE; Piekarczyk M; Dzuris J; Dykhuzen M; Mitchen J; Rudersdorf RA; Pauza CD; Sette A; Bontrop RE; DeMars R; Watkins DI
J Virol; 2000 Aug; 74(16):7400-10. PubMed ID: 10906193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
